On June 25, 2021, Artius Acquisition, Inc consummated the Business Combination
with Legacy Origin pursuant to the Merger Agreement. In connection with the
closing of the Business Combination, Artius changed its name to Origin
Materials, Inc. Legacy Origin was deemed to be the accounting acquirer in the
Merger. While Artius was the legal acquirer in the Merger, because Legacy Origin
was deemed the accounting acquirer, the historical consolidated financial
statements of Legacy Origin became the historical consolidated financial
statements of the combined company, upon the consummation of the Merger.
The following discussion and analysis should be read in conjunction with our
unaudited condensed consolidated financial statement the related notes appearing
elsewhere in this Report. This discussion may contain forward-looking statements
based upon current expectations that involve risks and uncertainties. Our actual
results may differ materially from those anticipated in these forward-looking
statements as a result of various factors, including those set forth in the
sections titled "Cautionary Note Regarding Forward-Looking Statements" and "Risk
Factors" as set forth elsewhere in this Report. Unless the context otherwise
requires, references in this section to "Legacy Origin", "the Company", "we",
"us" and "our" refer to the business and operations of Legacy Origin and its
consolidated subsidiaries prior to the Business Combination and to Origin
Materials, Inc. and its consolidated subsidiaries, following the Closing.
Overview
Origin is a carbon negative materials company with a mission to enable the
world's transition to sustainable materials by replacing petroleum-based
materials with decarbonized materials in a wide range of end products, such as
food and beverage packaging, clothing, textiles, plastics, car parts, carpeting,
tires, adhesives, soil amendments and more. We believe that our platform
technology can help make the world's transition to "net zero" possible and
support the fulfillment of greenhouse gas reduction pledges made by countries as
part of the United Nations Paris Agreement as well as corporations that are
committed to reducing emissions in their supply chains. Our technology converts
sustainable feedstocks such as sustainably harvested wood, agricultural waste,
wood waste and even corrugated cardboard into materials and products that are
currently made from fossil feedstocks such as petroleum and natural gas. These
sustainable feedstocks are not used in food production, which differentiates our
technology from other sustainable materials companies that use feedstocks such
as vegetable oils or high fructose corn syrup and other sugars. While we have
has succeeded in producing small amounts of our products in the pilot plant for
customer trials and testing purposes, we have has not yet commenced large-scale
production.
We believe that products made using our platform technology can compete directly
with petroleum-derived products on both performance and price. Due to abundant
and renewable wood supplies that have historically stable pricing, our cost of
production is expected to be more stable than potential competing platforms that
use other types of feedstocks. We believe that end products made using our
platform technology will have a significant unit cost advantage over products
made from other low carbon feedstocks.
We have developed a proprietary platform technology to convert biomass, or
plant-based carbon, into the versatile "building block" chemicals CMF and HTC,
as well as other product intermediates. At a commercial scale, our platform
technology is expected to produce CMF and HTC with a negative carbon footprint.
Origin believes these chemicals can replace petroleum-based counterparts,
lowering the carbon footprint of a wide range of materials without sacrificing
performance or cost.

                                       32
--------------------------------------------------------------------------------
  Table of Contents
We are currently developing and constructing our first manufacturing plant in
Ontario, Canada (Origin 1), which is expected to become operational by the end
of 2022. We are also currently in the planning phase for the construction of a
significantly larger manufacturing plant (Origin 2), which is expected to become
operational in 2025.
Impact of the
COVID-19
Pandemic
In March 2020, the
COVID-19
outbreak was declared a pandemic by the World Health Organization. The pandemic
has resulted in governments around the world implementing increasingly stringent
measures to help control the spread of the virus, including quarantines,
"shelter in place" and "stay at home" orders, travel restrictions, business
curtailments, school closures and other measures. In addition, governments and
central banks in several parts of the world have enacted fiscal and monetary
stimulus measures to counteract the impacts of the
COVID-19
pandemic.
We continue to monitor the rapidly evolving conditions and circumstances, as
well as guidance from international and domestic authorities, including public
health authorities, and we may need to take additional actions based on their
recommendations. There is considerable uncertainty regarding the impact on our
business stemming from current measures and potential future measures that could
restrict access to our facilities, limit manufacturing and support operations
and place restrictions on our workforce and suppliers. The measures implemented
by various authorities related to the
COVID-19
outbreak have caused us to change our business practices including those related
to where employees work, the distance between employees in our facilities,
limitations on
in-person
meetings between employees and with customers, suppliers, service providers and
stakeholders, as well as restrictions on business travel to domestic and
international locations or to attend trade shows, investor conferences and other
events.
The full extent to which the ongoing
COVID-19
pandemic adversely affects our financial performance will depend on future
developments, many of which are outside of our control, that are highly
uncertain and cannot be predicted, including, but not limited to, the duration
and spread of the pandemic, its severity, the effectiveness of actions to
contain the virus (including the availability and effectiveness of vaccines) or
treat its impact, and how quickly and to what extent normal economic and
operating conditions can resume. The
COVID-19
pandemic could also result in additional governmental restrictions and
regulations, which could harm Origin's business and financial results. In
addition, a recession, depression or other sustained adverse market impact
resulting from
COVID-19
could harm our business and its access to needed capital and liquidity. Even
after the
COVID-19
pandemic has subsided, Origin may continue to experience adverse impacts on its
business and financial performance as a result of the global economic impact of
the
COVID-19
pandemic.
To the extent that the
COVID-19
pandemic adversely affects our business, results of operations, financial
condition or liquidity, it may also heighten other risks, such as the risk that,
if the business impacts of
COVID-19
carry on for an extended period, we may be required to recognize impairments for
certain long-lived assets including amortizable intangible assets.
Key Factors and Trends Affecting Origin's Operating Results
We are a
pre-revenue
company. We believe that our performance and future success depend on several
factors that present significant opportunities for us but also pose risks and
challenges, including those discussed below and under "Risk Factors
"
appearing elsewhere in this Report.
Basis of Presentation
We currently conduct our business through one operating segment. As a
pre-revenue
company with no commercial operations, our activities to date have been limited,
and our historical results are reported under U.S. GAAP and in U.S. Dollars.
Upon commencement of commercial operations, we expect to expand our operations
substantially, including in the United States and Canada, and as a result, we
expect its future results to be sensitive to foreign currency transaction and
translation risks and other financial risks that are not reflected in its
historical financial statements. As a result, we expect that the financial
results we report for periods after we begin commercial operations will not be
comparable to the financial results included in this Report.

                                       33
--------------------------------------------------------------------------------
  Table of Contents
Components of Results of Operations
We are a
pre-revenue
company and our historical results may not be indicative of our future results
for reasons that may be difficult to anticipate. Accordingly, the drivers of our
future financial results, as well as the components of such results, may not be
comparable to our historical or projected results of operations.
Research and Development Expenses
To date, our research and development expenses have consisted primarily of
development of our four key product intermediates CMF, HTC, levulinic acid and
furfural, and the conversion of those intermediates into products familiar to
and desired by our customers, such as PX and PET. Our research and development
expenses also include investments associated with the expansion of the Origin 1
plant and planning and construction of the Origin 2 plant, including the
material and supplies to support product development and process engineering
efforts. As we ramp up our engineering operations to complete the development of
the Origin 1 and Origin 2 plants, we anticipate that research and development
expenses will increase significantly in the foreseeable future, due to expansion
in hiring and increase in investment in additional plant and equipment for
product development and testing.
General and Administrative Expenses
General and administrative expenses consist primarily of personnel-related
costs, including stock-based compensation, professional fees, including, the
costs of accounting, audit, legal, regulatory and tax compliance.
Additionally, costs related to advertising, trade shows, corporate marketing, as
well as an allocated portion of our occupancy costs also comprise general and
administrative expenses.
Change in Fair Value of Assumed Common Stock Warrant Liability
The change in fair value of Assumed Common Stock Warrant liabilities consists of
the change in fair value of the Public Warrants and Private Placement Warrants
assumed in connection with the Business Combination. We expect to incur an
incremental income (expense) for the fair value adjustments for the outstanding
Assumed Common Stock Warrant liabilities at the end of each reporting period or
through the exercise of the warrants.
Other (Income) Expense
Our other income (expense) consists of income from governmental grant programs,
interest expense for convertible notes and income or expenses related to changes
in the fair value of redeemable convertible preferred stock warrants liability
and derivative liability.
Income Tax Expense (Benefit)
Our income tax provision consists of an estimate for U.S. federal and state
income taxes based on enacted rates, as adjusted for allowable credits,
deductions, uncertain tax positions, changes in deferred tax assets and
liabilities, and changes in the tax law. We maintain a valuation allowance
against the full value of our U.S. and state net deferred tax assets because we
believe the recoverability of the tax assets is not more likely than not.

                                       34
--------------------------------------------------------------------------------
  Table of Contents
Non-GAAP
Measures
To
provide investors with additional information in connection with our results as
determined in accordance with GAAP, we disclose Adjusted Net Income as a
non-GAAP
measure. This measure is not a financial measure calculated in accordance with
GAAP, and it should not be considered as a substitute for net income, operating
income, or any other measure calculated in accordance with GAAP, and may not be
comparable to similarly titled measures reported by other companies.
Adjusted EBITDA
We believe that the presentation of Adjusted Earnings before Interest, Taxes,
Depreciation, and Amortization (Adjusted EBITDA) is appropriate to provide
additional information to investors about our operating profitability adjusted
for certain
non-cash
items,
non-routine
items that we do not expect to continue at the same level in the future, as well
as other items that are not core to our operations. Further, we believe Adjusted
EBITDA provides a meaningful measure of operating profitability because we use
it for evaluating our business performance, making budgeting decisions, and
comparing our performance against that of other peer companies using similar
measures.
We define Adjusted EBITDA as net income or loss adjusted for (i) stock-based
compensation expense, (ii) depreciation and amortization, (iii) interest
expense, net of capitalized interest, (iv) change in fair value of derivative
liability, (v) change in fair value of warrants liability, (vi) change in fair
value of earnout liability, and (vii) other income, net.

                                                    Three Months Ended              Six Months Ended
                                                         June 30,                       June 30,
                                                   2021            2020           2021            2020
Net Income (loss)                                $  62,531       $ (1,693 )     $   8,961       $ (3,663 )
Stock based compensation                             3,545              9           4,172             18
Depreciation and amortization                          121            100             236            204
Interest expense, net of capitalized interest        2,560             50           2,839            113
Change in fair value of derivative liability         1,035            (12 )         1,426            (15 )

Change in fair value of warrants liability (27,265 ) 105

        20,844            105
Change in fair value of earnout liability          (45,497 )           -          (45,497 )           -
Other Income, net                                      (42 )         (157 )          (624 )         (168 )

Adjusted EBITDA                                  $  (3,012 )     $ (1,598 )     $  (7,643 )     $ (3,406 )




                                       35

--------------------------------------------------------------------------------
  Table of Contents
Results of Operations
Comparison of the Six Months Ended June 30, 2021 and 2020
The following table summarizes the Company's results of operations with respect
to the items set forth in such table for the six months ended June 30, 2021 and
2020 together with the change in such items in dollars and as a percentage.

                                                Six Months Ended
                                                    June 30,
(in thousands)                                2021            2020         Variance        Variance %
Operating expenses:
Research and development                    $   3,648       $  2,122       $   1,526                72 %
General and administrative expenses             8,167          1,302           6,865               527 %
Depreciation and amortization                     236            204              32                15 %

Total operating expenses and loss from
operations                                     12,051          3,628           8,423               232 %
Other (income) expenses:
Interest expense, net of capitalized
interest                                        2,839            113           2,726               n.m
Change in fair value of derivative
liability                                       1,426            (15 )         1,441               n.m
Change in fair value of warrant
liability                                      20,844            105          20,739               n.m
Change in fair value of earnout
liability                                     (45,497 )           -          (45,497 )             n.m
Other income, net                                (623 )         (168 )          (455 )             271 %

Total other expense (income), net             (21,011 )           35         (21,046 )             n.m

Net Income (Loss)                           $   8,960       $ (3,663 )     $  12,623              (345 )%




n.m. - not meaningful.
Research and Development Expenses
Research and development expenses increased $1.5 million, or 72%, from 2020
compared to 2021. This increase was primarily due to increases of $1.0 million
in stock compensation related to additional stock grants and $0.5 million
related to incremental research and development staffing.
General and Administrative Expenses
General and administrative expenses increased $6.8 million, or 527%, from 2020
compared to 2021. This increase was primarily related to increased of
$3.2 million in stock compensation expenditures and $3.4 million supporting
construction of Origin 1, including additional hiring of personnel within
executive, accounting, procurement, sales, and supply-chain development, as well
as services in support of the Merger.
Interest Income (expense)
Interest expense increased $2.7 million from 2020 compared to 2021. This is due
to the conversion of stockholder convertible notes as a result of the business
combination and the elimination of the associated debt discount.

                                       36
--------------------------------------------------------------------------------
  Table of Contents
Change in fair value of derivative liability, warrant liability, and earnout
liability
The fair values of the derivative liability, the warrant liability, and the
earnout liability decreased a total of $23.3 million from 2020 to 2021. The
earnout liability and a portion of the change in the warrant liability are from
newly created liabilities from the business combination, with a combined
decrease in fair value of $59 million resulting from the change in fair value of
these instruments over the period from the closing of the merger to June 30,
2021. The remaining combined increase in fair value of $82.3 million resulting
from an increase in the liabilities due to the closing of the business
combination becoming more likely, eventually occurring on June 25, 2021.
Other Income, net
Other expense increased a total of $0.5 million from 2020 compared to 2021. This
change was primarily due to increasing funding from government grants.
Comparison of the Three Months Ended June 30, 2021 and March 31, 2021
The following table summarizes the Company's results of operations with respect
to the items set forth in such table for the three months ended June 30, 2021
and 2020 together with the change in such items in dollars and as a percentage.

                                                Three Months Ended
(in thousands)                         June 30, 2021         March 31, 2021         Variance         Variance%
Operating expenses:
Research and development              $         2,339       $          1,309       $    1,030                79 %
General and administrative
expenses                                        4,219                  3,948              271                 7 %
Depreciation and amortization                     121                    115                6                 5 %

Total operating expenses and loss
from operations                                 6,679                  5,372            1,307                24 %


Other (income) expenses:
Interest income                                 2,560                    279            2,281               n.m
Change in fair value of derivative
liability                                       1,035                    391              644               165 %
Change in fair value of warrant
liabilities                                   (27,265 )               48,109          (75,374 )            (157 )%
Change in fair value of earnout
liability                                     (45,497 )                   -           (45,497 )             n.m
Other income, net                                 (42 )                 (581 )            538               (93 )%

Total other (income) expenses, net            (69,210 )               48,198         (117,408 )            (244 )%

Net Income (loss)                     $        62,531       $        (53,570 )     $  116,101               217 %



Research and Development Expenses
Research and development expenses increased $1.0 million, or 79%, from the
previous quarter. This increase was due to increases of $0.7 million in stock
compensation related to additional stock grants and $0.3 million related to
incremental research and development staffing.

                                       37
--------------------------------------------------------------------------------
  Table of Contents
General and Administrative Expenses
General and administrative expenses increased $0.3 million, or 7%, from the
previous quarter. This increase was primarily related to increased stock
compensation expenditures of $2.3 million and $0.4 million supporting
construction of Origin 1, including additional hiring of personnel within
executive, accounting, procurement, sales, and supply-chain development, offset
by a decrease of $2.3 million in expenditures in preparation of efforts
preceding the Merger Agreement.
Interest Income (expense)
Interest income (expense) decreased $2.3 million from the previous quarter. This
is due to the conversion of stockholder convertible notes as a result of the
business combination and the elimination of the associated debt discount.
Change in fair value of derivative liability, warrant liability, and earnout
liability
The fair values of the derivative liability, the warrant liability, and the
earnout liability decreased a total of $120.2 million from the previous quarter.
The earnout liability and a portion of the change in the warrant liability are
from newly created liabilities from the business combination, with a combined
decrease in fair value of $59 million resulting from the change in fair value of
these instruments over the period from the closing of the merger to June 30,
2021. The remaining combined increase in fair value of $179.2 million resulting
from an increase in the liabilities due to the closing of the business
combination becoming more likely, eventually occurring on June 25, 2021.
Other Income, net
Other expense decreased a total of $0.6 million from the previous quarter. This
change was primarily due to increasing funding from government grants.
Liquidity and Capital Resources
Sources of Liquidity
Since inception, we have financed our operations principally from the sales and
issuances of redeemable preferred stock and convertible notes, and governmental
grant programs. Origin had $470.9 million and $1.9 million in cash, cash
equivalents and restricted cash as of June 30, 2021 and December 31, 2020,
respectively. Our cash equivalents are invested primarily in U.S. Treasury money
market funds and Origin's marketable securities are primarily U.S. Treasury
notes and bonds.
We are yet to generate any revenue from our business operations. Our ability to
successfully develop the products, commence commercial operations and expand the
business will depend on many factors, including our ability to meet the working
capital needs, the availability of equity or debt financing and, over time, our
ability to generate cash flows from operations.
We will require a significant amount of cash for capital expenditures as we
invest in the construction of Origin 1 and Origin 2 plants, and additional
research and development. In addition to our cash on hand following the Business
Combination, including the proceeds from the PIPE Investment, we anticipate that
we will need substantial additional project financing and government incentives
to meet our financial projections, execute our growth strategy and expand our
manufacturing capability, including to finance the construction of the Origin 1
and Origin 2 plants. Our ability to obtain financing for the construction of
future plants may depend in part on our ability to first enter into customer
agreements sufficient to demonstrate sufficient demand to justify the
construction of such plants. We may also raise additional capital through equity
offerings or debt financings, as well as through collaborations, strategic
alliances or marketing, distribution or licensing arrangements with third
parties. Our future capital requirements will

                                       38
--------------------------------------------------------------------------------
  Table of Contents
depend on many factors, including actual construction costs of the Origin 1 and
Origin 2 plants, changes in the costs in our supply chain, expanded operating
activities and our ability to secure customers. If our financial projections are
inaccurate, we may need to seek additional equity or debt financing from outside
sources, which may not be available on acceptable terms, if at all. If we are
unable to raise additional capital when required, our business, financial
condition and results of operations would be harmed.
We expect to continue to incur operating losses in the near term as our
operating and capital expenses will increase to support the growth of the
business. We expect that our general and administrative expenses and research
and development expenses will continue to increase as we increase our sales and
marketing activities, develop our distribution infrastructure, support our
growing operations and operate as a public company.
Indebtedness
In November 2019, Legacy Origin entered into secured convertible note agreements
(the "2019 Notes") with certain Legacy Origin preferred stockholders, whereby
Legacy Origin can borrow up to $6.0 million in aggregate from the noteholders.
The 2019 Notes bear an annual interest rate of 10% and mature on September 30,
2021. All principal and accrued interest under the 2019 Notes were converted
into shares of Legacy Origin Common Stock immediately prior to the closing of
the Business Combination.
In April 2020, Legacy Origin received an unsecured loan in the amount of
$905,838 under the Paycheck Protection Program (the "PPP Loan"). The Paycheck
Protection Program was established under the CARES Act and is administered by
the U.S. Small Business Administration. The PPP Loan has a
two-year
term and bears interest at a rate of 1.00% per annum. This loan was repaid on
June 24, 2021.
As of June 30, 2021 and December 31, 2020, we have $6.4 million and $6.2 million
of indebtedness under a Canadian government program, respectively, of which
$2.7 million was received in 2020 and $0.1 million was received during the six
months ended June 30, 2021. Additionally, as of June 30, 2021, we had liability
balances consisting of a $5.2 million customer prepayment and $5.6 million
related party liabilities. As of December 2020, we had liability balances
consisting of a $2.5 million customer prepayment, a $5.5 million stockholder
note, and a $5.2 million customer prepayment.
During 2020, we received $550,000 for the admission of an additional member to a
consortium agreement with two Series B preferred stock investors and a Series C
investor to collaborate on development of a process to commercialize
bio-based,
decarbonizing materials for application on an industrial scale at a competitive
price. These funds were recorded as other income, net, in the condensed
consolidated statement of operations and comprehensive income and loss.
In February 2021, Legacy Origin issued and sold convertible promissory notes
with an aggregate principal amount of $10.0 million and an interest rate of 8.0%
per annum (the "2021 Notes"). The 2021 Notes mature on September 30, 2021. All
principal and accrued interest on the 2021 Notes were converted into shares of
Legacy Origin Common Stock immediately prior to the closing of the Business
Combination.
In November 2016, Legacy Origin received a $5.0 million prepayment from a
stockholder for product from Origin 1 pursuant to an Offtake Agreement. The
prepayment was to be credited against the purchase of products over the term of
the agreement. The prepayment was secured by a promissory note to be repaid in
cash in the event that the prepayment could not be credited against the purchase
of product, for example, if Origin 1 is never constructed. The promissory note
was collateralized substantially by Origin 1 and other assets of Origin Material
Canada Pioneer Limited. In May 2019, Legacy Origin and the stockholder amended
the offtake agreement and promissory note. The amendment added accrued interest
of $189,169 to the principal balance of the prepayment and provided for the
prepayment amount to be repaid in three annual installments rather than being
applied against the purchase of product from Origin 1. The promissory note would
bear interest at 3.50% per annum and be repaid in three installments

                                       39
--------------------------------------------------------------------------------
  Table of Contents
of $2.2 million, $2.1 million and $2.1 million (inclusive of accrued but unpaid
interest) on December 20, 2024, December 19, 2025, and December 18, 2026,
respectively, unless the 2019 Notes have not been converted or repaid by
December 30, 2021, in which case the promissory note maturity date would be
December 31, 2021. The promissory note is subordinate to the 2019 Notes. At
June 30, 2021 and December 31, 2020, the total aggregate principal amount of
debt outstanding was $5.2 million and accrued interest totaled $0.4 million and
$0.3 million, respectively.
Prepayments
In November 2016, Legacy Origin received a $5.0 million prepayment from a
stockholder for product from Origin 1 pursuant to an Offtake Agreement. The
prepayment is to be credited against the purchase of products from Origin 1 over
the term of the Offtake Agreement. Specifically, repayment is effected by
applying a credit to product purchases each month over the first five years of
operation of Origin 1 up to $7.5 million, which is equal to 150% of the
prepayment amount. If product purchases are not sufficient to recover the
advances, the application of the credit to purchases as payment of the advances
will continue until fully repaid. The prepayment is secured by a note to be
repaid in cash in the event the prepayment cannot be credited against the
purchase of product, for example, if Origin 1 is never constructed. The note is
collateralized substantially by Origin 1 and other assets of Origin Material
Canada Pioneer Limited. If repaid in cash, the note bears an annual interest
rate of the three-month London Interbank Offered Rate (LIBOR) plus 0.25% (0.44%
at March 31, 2021) and matures five years from the commercial operation date of
Origin 1, unless the 2019 Notes have not been converted or repaid by
December 30, 2021, in which case the note maturity date would be December 31,
2021. The note is subordinated to the 2019 Notes. At June 30, 2021 and
December 31, 2020 the total note principal outstanding was $5.1 million plus
accrued interest of $0.5 million and $0.1 million, respectively.
In September 2019, Legacy Origin entered into a $5.0 million prepayment
agreement for the purchase of products from Origin 2. The prepayment is to be
made in two equal installments: the first $2.5 million was in October 2019 and
the remaining $2.5 million is due within 30 days of the customer confirming that
a sample from Origin 1 meets the customer's specifications. We and the customer
agreed to work in good faith to execute an Offtake Agreement, the agreed terms
of which are set forth in the prepayment agreement, whereby 100% of the
prepayment will be applied against future purchases. The prepayment agreement
provides the customer a capacity reservation of up to a specified annual volume
of product from Origin 1 for a term of ten years, pursuant to the terms of an
Offtake Agreement. At June 30, 2021 and December 31, 2020, the total amount
outstanding on this agreement was $2.5 million.
Cash Flows for the Six Months Ended June 30, 2021 Compared to the Six Months
Ended June 30, 2020
The following table shows a summary of cash flows for the six months ended
June 30, 2021 and 2020:

                                                             Six Months Ended June 30,
(in thousands)                                                 2021               2020
Total cash used in operating activities                    $      (6,675 )      $  (2,271 )
Total cash used in investing activities                           (2,703 )         (1,267 )
Total cash provided by financing activities                      478,559    

1,962

Effects of foreign exchange rate changes on the balance of cash and cash equivalents, and restricted cash held in foreign currencies

                                     (178 )  

184



Net increase (decrease) in cash                            $     469,003        $  (1,392 )




                                       40

--------------------------------------------------------------------------------
  Table of Contents
Cash Used in Operating Activities
Net cash used in operating activities was $6.7 million for the six months ended
June 30, 2021, compared to net cash used in operating activities of $2.3 million
over the same period in 2020. The decrease was primarily attributable to an
increase in net loss (after adjusting for
non-cash
items) and decreases in accounts payable.
Cash Used in Investing Activities
Net cash used in investing activities was $2.7 million for the six months ended
June 30, 2021, compared to net cash used in investing activities of $1.3 million
over the same period in 2020. The Company continues to increase activity related
to the construction of Origin 1, which is the main driver of the variation in
cash used in investing activities between the two periods.
Cash Provided by Financing Activities
Net cash from financing activities was $479 million for the six months ended
June 30, 2021, compared to net cash from financing activities of $2 million over
the same period in 2020. The Company completed a business combination during the
current period, netting cash proceeds of $467 million. Cash of $11.7 million was
provided by proceeds from notes payable, and payments of $0.9 million were made
on short term debt.
Off-Balance
Sheet Arrangements
The Company did not have any
off-balance
sheet arrangements during the periods presented, as defined in the rules and
regulations of the SEC.
Critical Accounting Policies and Estimates
Our financial statements have been prepared in accordance with U.S. GAAP. In the
preparation of these condensed consolidated financial statements, we are
required to use judgment in making estimates and assumptions that affect the
reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities as of the date of the financial statements, as well as
the reported expenses incurred during the reporting periods.
We consider an accounting judgment, estimate or assumption to be critical when
(1) the estimate or assumption is complex in nature or requires a high degree of
judgment and (2) the use of different judgments, estimates and assumptions could
have a material impact on the consolidated financial statements. Our significant
accounting policies are described in Note 3 to our unaudited condensed
consolidated financial statements included elsewhere in this Report. We have the
critical accounting policies and estimates which are described below.
Stock-Based Compensation
Origin measures stock options and other stock-based awards granted to employees,
directors and other service providers based on their fair value on the date of
grant and recognizes compensation expenses of those awards over the requisite
service period, which is generally the vesting period of the respective award.
Origin estimates forfeitures at the grant date based on historical activity of
the grantee class and adjust stock-based compensation expenses based on that
historical percentage. Origin applies the straight-line method of expense
recognition to all awards with only service-based vesting conditions.

                                       41
--------------------------------------------------------------------------------
  Table of Contents
Origin estimates the fair value of each stock option grant on the date of grant
using the Black-Scholes option-pricing model, which requires the use of highly
subjective assumptions including:
•
Expected Term
-Origin have opted to use the "simplified method" for estimating the expected
term of plain-vanilla options, whereby the expected term equals the arithmetic
average of the vesting term and the original contractual term of the option
(generally 10 years).
•
Risk-Free Interest Rate
-The risk-free rate assumption is based on the U.S. Treasury
zero-coupon
instruments with maturities similar to the expected term of Origin's stock
options.
•
Expected Dividend
-Origin has not issued any dividends and does not anticipate issuing dividends
on Origin's common stock. As a result, Origin has estimated the dividend yield
to be zero.
•
Expected Volatility
-Due to Origin's limited operating history and a lack of company-specific
historical and implied volatility data, Origin has based its estimate of
expected volatility on the historical volatility of a group of similar companies
that are publicly traded. The historical volatility data was computed using the
daily closing prices for the various companies' shares during the equivalent
period of the calculated expected term of the stock-based awards.
Warrant Liability
We account for the Warrants in accordance with the guidance contained in ASC
815-40-15-7D
and 7F under which the Warrants do not meet the criteria for equity treatment
and must be recorded as liabilities. Accordingly, we classify the Warrants as
liabilities at their fair value and adjust the Warrants to fair value at each
reporting period. This liability is subject to re-measurement at each balance
sheet date until exercised, and any change in fair value is recognized in our
statement of operations. The Private Warrants and the Public Warrants for
periods where no observable traded price was available are valued using a Monte
Carlo simulation. For periods subsequent to the detachment of the Public
Warrants from the Units, the Public Warrant quoted market price was used as the
fair value as of each relevant date.
Earnout Liability
The Company has recorded an earnout liability related to future contingent
equity shares related to the Business Combination (note 13). The Company
recorded these instruments as liabilities on the condensed consolidated balance
sheet at fair value, with subsequent changes in their respective fair values
recognized in earnings at each reporting date.
Net Loss Per Ordinary Share
We apply
the two-class method
in calculating earnings per share. Ordinary shares subject to possible
redemption, which are not currently redeemable and are not redeemable at fair
value, have been excluded from the calculation of basic net loss per ordinary
share since such shares, if redeemed, only participate in their pro rata share
of the Trust Account earnings. Our net income is adjusted for the portion of
income that is attributable to ordinary shares subject to redemption, as these
shares only participate in the earnings of the Trust Account and not our income
or losses.
Recent Accounting Pronouncements
See Note 5 to the condensed consolidated financial statements in this Report for
more information about recent accounting pronouncements, the timing of their
adoption, and our, to the extent it has made one, of their potential impact on
our financial condition and its results of operations and cash flows.

                                       42
--------------------------------------------------------------------------------
  Table of Contents
Emerging Growth Company Status
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being
required to comply with new or revised financial accounting standards until
private companies are required to comply with the new or revised financial
accounting standards. The JOBS Act provides that a company can choose not to
take advantage of the extended transition period and comply with the
requirements that apply to
non-emerging
growth companies, and any such election to not take advantage of the extended
transition period is irrevocable.
The Company is an "emerging growth company" as defined in Section 2(a) of the
Securities Act of 1933, as amended (the "Securities Act") and has elected to
take advantage of the benefits of the extended transition period for new or
revised financial accounting standards. The Company may decide to early adopt
such new or revised accounting standards to the extent permitted by such
standards. This may make it difficult or impossible to compare our financial
results with the financial results of another public company that is either not
an emerging growth company or is an emerging growth company that has chosen not
to take advantage of the extended transition period exemptions because of the
potential differences in accounting standards used.
We will remain an emerging growth company until the earliest of (i) the last day
of the fiscal year in which the market value of our Common Stock that is held
by non-affiliates equals
or exceeds $700 million as of the end of that year's second fiscal quarter,
(ii) the last day of the fiscal year in which we have total annual gross revenue
of $1.07 billion or more during such fiscal year (as indexed for inflation),
(iii) the date on which we have issued more than $1 billion
in non-convertible debt
in the prior three-year period or (iv) December 31, 2026. We will no longer
qualify as an emerging growth company for Securities Act or Exchange Act
reporting after December 31, 2021.
Implications of being a Smaller Reporting Company
Additionally, we qualify as a "smaller reporting company" as defined in Item
10(f)(1) of
Regulation S-K. Smaller
reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two years of audited
financial statements. We will remain a smaller reporting company until the last
day of the fiscal year in which (i) the market value of our Common Stock held
by non-affiliates exceeds
$250 million as of the end of that year's second fiscal quarter, or (ii) our
annual revenues exceeded $100 million during such completed fiscal year and the
market value of our Common Stock held
by non-affiliates equals
or exceeds $700 million as of the end of that year's second fiscal quarter. To
the extent we take advantage of such reduced disclosure obligations, it may also
make comparison of our financial statements with other public companies
difficult or impossible. We will no longer qualify as a smaller reporting
company for Securities Act or Exchange Act reporting after December 31, 2021.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The Company is exposed to a variety of markets and other risks, including the
effects of change in interest rates, inflation and foreign currency translation
and transaction risks, as well as risks to the availability of funding sources,
hazard events and specific asset risks.
Interest Rate Risk
The market interest risk in our financial instruments and our financial
positions represents the potential loss arising from adverse changes in interest
rates. As of June 30, 2021, we had cash and cash equivalents and marketable
securities of $2.5 million, consisting of interest-bearing money market accounts
and marketable securities, for which the fair market value would be affected by
change in the general level of U.S. interest rates. However, due to the
short-term maturities and the
low-risk
profile of our investments, an immediate 10% change in the interest rate would
not have a material effect on the fair market value of our cash and cash
equivalents and marketable securities.

                                       43
--------------------------------------------------------------------------------
  Table of Contents
Foreign Currency Risk
Our functional currency is the U.S. dollar, while certain of our current and
future subsidiaries will be expected to have other functional currencies,
reflecting their principal operating markets. We expect to be exposed to both
currency transaction and translation risk. To date, we have not had material
exposure to foreign currency fluctuations and have not hedged such exposure,
although we may do so in the future.
Item 4. Controls and Procedures
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures (as defined
in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act), management recognizes that any controls and procedures,
no matter how well designed and operated, can provide only reasonable assurance
of achieving the desired control objectives.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our chief executive officers and chief
financial officer, has evaluated the effectiveness of our disclosure controls
and procedures (as defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act) as of the end of the period covered by this Report.
The term "disclosure controls and procedures," as defined in Rules 13a15(e)
and 15d-15(e) under
the Securities Exchange Act of 1934, as amended, or the Exchange Act, means
controls and other procedures of a company that are designed to ensure that
information required to be disclosed by a company in the reports that it files
or submits under the Exchange Act is recorded, processed, summarized and
reported, within the time periods specified in the rules and forms of the
Securities and Exchange Commission, or SEC. Disclosure controls and procedures
include, without limitation, controls and procedures designed to ensure that
information required to be disclosed by a company in the reports that it files
or submits under the Exchange Act is accumulated and communicated to the
company's management, including its principal executive and principal financial
officers, as appropriate to allow timely decisions regarding required
disclosure. Management recognizes that any controls and procedures, no matter
how well designed and operated, can provide only reasonable assurance of
achieving their objectives and management necessarily applies its judgment in
evaluating the cost-benefit relationship of possible controls and procedures.
In connection with the audit of our consolidated financial statements for the
fiscal years ended December 31, 2019 and December 31, 2020, during the course of
preparing for the Business Combination, as well as during the preparation of the
unaudited condensed consolidated interim financial statements for this 10Q
filing, we identified material weaknesses in our internal controls over
financial reporting. A material weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting such that there is a
reasonable possibility that a material misstatement of its annual or interim
financial statements will not be prevented or detected on a timely basis
Specifically, we did not have in place an effective control environment with
formal processes and procedures to allow for a detailed review of accounting
transactions that would identify errors in a timely manner. In addition, due to
our size, we did not have proper segregation of duties and had insufficient
accounting and finance personnel with an appropriate level of technical
accounting knowledge in the application of U.S. GAAP commensurate with our
complexity and financial accounting and reporting requirements to design,
implement and operate precise business processes and internal control activities
over financial reporting to provide reasonable assurance of preventing or
detecting material misstatements.

                                       44
--------------------------------------------------------------------------------
  Table of Contents
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting (as
defined in Rules
13a-15(f)
and
15d-15(f)
under the Exchange Act), during the six months ended June 30, 2021 that has
materially affected, or is reasonably likely to materially affect, our internal
control over financial reporting, other than as described below under the
caption "Remediation Plan."
Remediation Plan
The Company is committed to remediating the material weakness to our internal
control over financial reporting. We have begun implementing and are continuing
to implement measures designed to improve our internal control over financial
reporting to remediate these material weaknesses, including retention of an
accounting consultant to assist in areas of complex accounting and financial
reporting, converting and upgrading our accounting system and hiring additional
IT personnel. We also plan to hire additional accounting personnel including a
staff accountant, a corporate controller and/or a director of SEC reporting.

                                       45

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses